MediGene AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
companies in this sector in Germany:
sales of 3.27 million Euro [US$3.53 million]
of which 70%
was Drug Discovery & Development),
(4.14 million Euro [US$4.47 million]
of which 100%
was Pharmaceuticals), and
(2.28 million Euro [US$2.47 million]
MediGene AG reported sales of 6.81 million Euro (US$7.35 million)
December of 2015.
decrease of 50.6%
versus 2014, when the company's sales were 13.78 million Euro.